Original language | English |
---|---|
Journal | Trials |
DOIs | |
Publication status | Published - 22 Aug 2017 |
Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial.
Laura Collett, DR Howard, T Munir, L McParland, JB Oughton, AC Rawstron, A Hockaday, C Dimbleby, D Phillips, K McMahon, C Hulme, D Allsup, A Bloor, P Hillmen
Research output: Contribution to journal › Article (Academic Journal) › peer-review
32
Citations
(Scopus)